immunotherapy

immunotherapy

Consolidative Thoracic Radiation Therapy (cTRT) Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Patrick DalySmall Cell Lung Cancer | September 21, 2023

Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...

Immunotherapy Combination Fails to Improve Survival in Patients With NSCLC

Kerri FitzgeraldNon-Small Cell Lung Cancer | September 19, 2023

The phase III ARTIC trial assessing the use of two immunotherapies—durvalumab and tremelimumab—for previously ...

Lung Cancer Patients With Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy

Rob DillardImmunotherapy in NSCLC | November 16, 2020

A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to ...

Latest News

Testing Category 1

August 29, 2025

Guided by Data: Navigating Biopsies, Biomarkers, and Treatment Strategies in NSCLC

August 13, 2025

From Screening to Strategy: Navigating the First Steps in Lung Cancer Care

August 12, 2025

FDA Grants Accelerated Approval to Zongertinib for NSCLC With HER2 TKD-Activating Mutations

August 11, 2025

Surgery for NSCLC: Multidisciplinary Panel Discusses Operative Considerations

August 11, 2025

Managing Side Effects in Patients With NSCLC: Experts Share Strategies

August 11, 2025

Physician's Weekly

Family Practice

FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks

Family Practice

Most Major Ice Cream Brands Will Remove Synthetic Dyes by 2028

Dermatology

Atopic Dermatitis May Be Linked to Increased Risk for CKD